| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016671 |
| Receipt No. | R000019349 |
| Official scientific title of the study | The effectiveness of the ultrasound-guided thoracic wall nerve blocks to the breast surgery. |
| Date of disclosure of the study information | 2015/05/01 |
| Last modified on | 2018/12/11 (Ver. 13) |
| Basic information | ||
| Official scientific title of the study | The effectiveness of the ultrasound-guided thoracic wall nerve blocks to the breast surgery. | |
| Title of the study (Brief title) | The effectiveness of the ultrasound-guided thoracic wall nerve blocks to the breast surgery. | |
| Region |
|
|
| Condition | |||
| Condition | Elective mastectomy for breast cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | In this study I consider the effectiveness of acute pain and chronic pain of breast cancer after surgery due to Thoracic wall nerve block (PECS2 block and serratus plane block). |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Chronic pain after 6 months
(use NRS;Numeric Rating Scale) |
| Key secondary outcomes | Chronic pain after 2 months
(use NRS;Numeric Rating Scale) Acute pain after 24 hours (use VAS;Visual Analog Scale) Dose of postoperative morphine Health Related Quality of Life after 2 months and 6 months (use EuroQol-5D) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | PECS2 block | |
| Interventions/Control_2 | Serratus plane block | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Elective mastectomy for breast cancer
American Society of Anesthesiologists Physical Status Classification 1-2 Preoperative ADL is independence Written informed consent is provided |
|||
| Key exclusion criteria | Consciousness disabilities
Enough judgment ability nothing Male Emergency ASA-PS over 3 History of hypersensitivity to ropivacaine or amide type local anesthetic Hemodialysis Renal dysfunction (less than eGFR30) Liver dysfunction (Child-Pugh classification more B) Blood clotting disorder (less than 100,000 platelets/mcl, PT-INR 1.5 or more, less than APTT% 70%) |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Kimitoshi Nishiwaki |
| Organization | Nagoya University Graduate School of Medicine |
| Division name | Department of Anesthesiology |
| Address | 65 Tsuruna-cho, Showa-ku, Nagoya, 466-8550 Japan |
| TEL | 052-744-2340 |
| nishi@med.nagoya-u.ac.jp | |
| Public contact | |
| Name of contact person | Tasuku Fujii |
| Organization | Nagoya University Hospital |
| Division name | Department of Anesthesiology |
| Address | 65 Tsuruna-cho, Showa-ku, Nagoya, 466-8550 Japan |
| TEL | 052-744-2340 |
| Homepage URL | |
| plus9@med.nagoya-u.ac.jp | |
| Sponsor | |
| Institute | Nagoya University Graduate School of Medicine, Biomedical Regulation, Department of Anesthesiology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nagoya University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 名古屋大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019349 |